JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 37 No. 4 554-559
© 1996 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Gur, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Gur, R.

Dopamine Transporters Decrease with Age

Nora D. Volkow , Yu-Shin Ding, Joanna S. Fowler, Gene-Jack Wang, Jean Logan, S. John Gatley, Robert Hitzemann, Gwenn Smith, Suzanne D. Fields and Ruben Gur

Medical and Chemistry Departments Brookhaven National Laboratory, Upton, New York
Departments of Psychiatry and Medicine, Division of Geriatrics, SUNY-Stony Brook, Stony Brook, New York
Department of Psychiatry, New York University, New York, New York
Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: Nora D. Volkow, MD, Medical Department, Brookhaven National Laboratory, Upton, NY 11973.

ABSTRACT

Postmortem studies have documented degeneration of dopamine cells with age, but the changes that occur in healthy aging individuals is less clear. The purpose of this study was to evaluate the extent to which age-induced changes in dopamine transporters occur in subjects with no evidence of motor impairment. Methods: We evaluated 23 right-handed healthy volunteers (age range 20–74 yr) using PET and [11C]d-threo-methylphenidate. The ratio of the distribution volume for [11C]d-threo-methylphenidate in striatum to that in cerebellum was used as model parameter for dopamine transporter availability (Bmax/Kd + 1). Results: Dopamine transporter availability, was significantly lower in subjects >40 yr of age than in those <40 yr. Estimates of dopamine transporter availability showed a significant negative correlation with age both for the putamen (r = –0.72, p < 0.0001) and the caudate (r = –0.74, p < 0.0001). Dopamine transporter availability was higher in the left than in the right putamen but did not differ between the left and right caudate. Conclusion: This study documents a 6.6% decrease per decade of life in striatal dopamine transporters of healthy volunteers.

Key Words: PET • dopamine transporters • degeneration




This article has been cited by other articles:


Home page
Cereb CortexHome page
S. M. Landau, R. Lal, J. P. O'Neil, S. Baker, and W. J. Jagust
Striatal Dopamine and Working Memory
Cereb Cortex, June 11, 2008; (2008) bhn095v1.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
A. Diamond
Consequences of Variations in Genes that affect Dopamine in Prefrontal Cortex
Cereb Cortex, September 1, 2007; 17(suppl_1): i161 - i170.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R Vandenberghe and J Tournoy
Cognitive aging and Alzheimer's disease
Postgrad. Med. J., June 1, 2005; 81(956): 343 - 352.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. H. van Dyck, R. T. Malison, L. K. Jacobsen, J. P. Seibyl, J. K. Staley, M. Laruelle, R. M. Baldwin, R. B. Innis, and J. Gelernter
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene
J. Nucl. Med., May 1, 2005; 46(5): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M.-J. Ribeiro, M. Vidailhet, C. Loc'h, C. Dupel, J. P. Nguyen, M. Ponchant, F. Dolle, M. Peschanski, P. Hantraye, P. Cesaro, et al.
Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease
Arch Neurol, April 1, 2002; 59(4): 580 - 586.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V.S. Mattay, F. Fera, A. Tessitore, A.R. Hariri, S. Das, J.H. Callicott, and D.R. Weinberger
Neurophysiological correlates of age-related changes in human motor function
Neurology, February 26, 2002; 58(4): 630 - 635.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
C. H. van Dyck, J. P. Seibyl, R. T. Malison, M. Laruelle, S. S. Zoghbi, R. M. Baldwin, and R. B. Innis
Age-Related Decline in Dopamine Transporters: Analysis of Striatal Subregions, Nonlinear Effects, and Hemispheric Asymmetries
Am J Geriatr Psychiatry, February 1, 2002; 10(1): 36 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y.-S. Ding, et al.
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
J. Neurosci., December 1, 2001; 21(23): 9414 - 9418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori
Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET
Am J Psychiatry, August 1, 2001; 158(8): 1206 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
T. P. J. Laine, A. Ahonen, P. Rasanen, T. Pohjalainen, J. Tiihonen, and J. Hietala
The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics
Alcohol Alcohol., May 1, 2001; 36(3): 262 - 265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, M. Leonido-Yee, D. Franceschi, M. J. Sedler, S. J. Gatley, R. Hitzemann, Y.-S. Ding, et al.
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Am J Psychiatry, March 1, 2001; 158(3): 377 - 382.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
L. K. Jacobsen, J. K. Staley, R. T. Malison, S. S. Zoghbi, J. P. Seibyl, T. R. Kosten, and R. B. Innis
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
Am J Psychiatry, July 1, 2000; 157(7): 1134 - 1140.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, J. Logan, J. S. Fowler, G.-J. Wang, R. C. Gur, C. Wong, C. Felder, S. J. Gatley, Y.-S. Ding, R. Hitzemann, et al.
Association Between Age-Related Decline in Brain Dopamine Activity and Impairment in Frontal and Cingulate Metabolism
Am J Psychiatry, January 1, 2000; 157(1): 75 - 80.
[Abstract] [Full Text]


Home page
J Geriatr Psychiatry NeurolHome page
C. C. Meltzer
Neuropharmacology and Receptor Studies in the Elderly
J Geriatr Psychiatry Neurol, October 1, 1999; 12(3): 137 - 149.
[Abstract] [PDF]


Home page
BrainHome page
G. Esposito, B. S. Kirkby, J. D. Van Horn, T. M. Ellmore, and K. F. Berman
Context-dependent, neural system-specific neurophysiological concomitants of ageing: mapping PET correlates during cognitive activation
Brain, May 1, 1999; 122(5): 963 - 979.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Ilgin, J. Zubieta, S. G. Reich, R. F. Dannals, H. T. Ravert, and J. J. Frost
PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
Neurology, April 1, 1999; 52(6): 1221 - 1221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
B Jeon, J M Kim, J M Jeong, K M Kim, Y S Chang, D S Lee, and M C Lee
Dopamine transporter imaging with [123I]-beta -CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 60 - 64.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, R. C. Gur, G.-J. Wang, J. S. Fowler, P. J. Moberg, Y.-S. Ding, R. Hitzemann, G. Smith, and J. Logan
Association Between Decline in Brain Dopamine Activity With Age and Cognitive and Motor Impairment in Healthy Individuals
Am J Psychiatry, March 1, 1998; 155(3): 344 - 349.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1996 by the Society of Nuclear Medicine.